GSK Plc (GLAXF)

25.00 +1.14 (+4.78%) USD  |  OTCM  |  Dec 09, 15:10
More

GSK EPS Diluted (5 Year Growth)

EPS Diluted (5 Year Growth) Chart

View EPS Diluted (5 Year Growth) for GLAXF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View EPS Diluted (5 Year Growth) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

EPS Diluted (5 Year Growth) Range, Past 5 Years

View EPS Diluted (5 Year Growth) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

EPS Diluted (5 Year Growth) Benchmarks

View EPS Diluted (5 Year Growth) Benchmarks
Start Trial
Biodexa Pharmaceuticals Plc Upgrade
NuCana Plc Upgrade
Autolus Therapeutics Plc Upgrade
Tiziana Life Sciences Ltd. Upgrade
Aptorum Group Ltd. Upgrade